Eckhardt Sue Gail 4
4 · Syros Pharmaceuticals, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
Eckhardt Sue Gail
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-05+6,000→ 6,000 totalExercise: $5.30Exp: 2034-06-04→ Common Stock (6,000 underlying) - Award
Common Stock
2024-06-05+4,000→ 16,000 total
Footnotes (1)
- [F1]The option becomes exercisable as to 50% of the shares underlying the award on the six month anniversary of the date of grant, with the remainder vesting in equal monthly installments of 8.33% of the shares underlying the award until the first anniversary of the date of grant, subject to the reporting person's continued service as a director through each applicable vesting date.